{
    "paper_id": "PMC7152123",
    "metadata": {
        "title": "Disorders of the Brain",
        "authors": [
            {
                "first": "Scott",
                "middle": [
                    "J."
                ],
                "last": "Schatzberg",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Rhea",
                "middle": [
                    "V."
                ],
                "last": "Morgan",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "\nI.Dysfunction of the peripheral vestibular system is seen in young dogs and cats, possibly from a congenital defect.II.The disorder is presumed to be inherited.III.It has been reported in the following breeds:A.Dogs: Doberman pinscher, American cocker spaniel, German shepherd dog, Akita, beagleB.Cats: Siamese, Burmese\nIV.Aggregates of lymphocytes occur within the inner ear of affected Doberman puppies, but the significance of these lesions is unclear.\n",
            "cite_spans": [],
            "section": "Definition and Causes ::: Definition and Causes ::: Congenital Vestibular Disease ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Onset of signs is usually 3 to 12 weeks of age.II.Head tilt, vestibular ataxia, circling, and deafness may be seen.III.Nystagmus is not a feature of this disorder.IV.Diagnosis is one of exclusion: rule out other causes of vestibular signs.\n",
            "cite_spans": [],
            "section": "Clinical Signs and Diagnosis ::: Definition and Causes ::: Congenital Vestibular Disease ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Otitis media/internaII.Ototoxicity: aminoglycoside antibiotics, topical antiseptics (iodophors, chlorhexidine)\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Congenital Vestibular Disease ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No treatment is available.II.Compensation for the vestibular signs may occur over several weeks.III.Deafness (if present) is typically permanent.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Congenital Vestibular Disease ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is an increase in the volume of cerebrospinal fluid (CSF) within the ventricular system or subarachnoid space of the brain (de Lahunta, 1983).II.In compensatory hydrocephalus, CSF accumulates in spaces within the cranial cavity not occupied by brain parenchyma.III.In obstructive hydrocephalus, obstruction to flow or absorption of CSF causes ventricular dilation (especially of the lateral ventricles) with subsequent loss of brain parenchyma.\n",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 146,
                    "mention": "de Lahunta, 1983",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Definition ::: Definition ::: Hydrocephalus ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Compensatory hydrocephalus may result from the following:A.Developmental malformations: cerebral hypoplasia or aplasiaB.Destruction of brain parenchyma from in utero viral infections: feline panleukopeniaC.Cerebral necrosis secondary to cerebrovascular accidents: acquired hydrocephalus\nII.Obstructive hydrocephalus may result from the following:A.Fusion of rostral colliculi (midbrain) with CSF outflow obstruction at the mesencephalic aqueductB.Dysfunction of the arachnoid villi with poor reabsorption of CSF through the dorsal sagittal venous sinus\nIII.Acquired hydrocephalus may result from the following:A.Mass lesions blocking CSF flow: neoplasia, abscess, granulomaB.Neoplasia preventing CSF absorption by the arachnoid villiC.Infections (viral, bacterial) or inflammation of the ependyma of the mesencephalic aqueduct or leptomeninges blocking flow of CSFD.Intraventricular hemorrhage blocking CSF outflow: leptomeningeal, intraventricular\n\n",
            "cite_spans": [],
            "section": "Causes ::: Definition ::: Hydrocephalus ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No or variable signs may be seen, even in the presence of considerable ventricular dilatation.II.Prosencephalic signs include disturbed consciousness (lethargy to severe depression), increased tendency to sleep, hypoactivity, propulsive circling, head pressing, seizures, behavioral changes, dementia, and visual deficits (with normal pupillary responses).III.Motor deficits include spastic paresis, particularly if the brainstem is involved.IV.Occasionally cerebellar ataxia may occur if there is involvement of the cerebellum.V.Sensory deficits include proprioceptive ataxia.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition ::: Hydrocephalus ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Presumptive diagnosis is based on physical examination findings.A.Animals with congenital hydrocephalus often have palpable open fontanelles and develop a dome-shaped calvaria.B.Ventral-lateral strabismus may be noted.\nII.Imaging findingsA.Skull radiographs may reveal a homogenous \u201cground glass\u201d appearance within the calvaria and open cranial suture lines.B.Ventriculomegaly may be demonstrated by computed tomography (CT), magnetic resonance imaging (MRI), and occasionally ultrasonography.\n\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition ::: Hydrocephalus ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Other congenital brain anomaliesIV.Degenerative encephalopathies\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition ::: Hydrocephalus ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Corticosteroids may decrease CSF production.A.Prednisone 0.25 to 0.5 mg/kg PO BID, then tapered to QODB.Dexamethasone 0.05 mg/kg PO SID, then tapered to QODC.May be discontinued in some dogs\nII.Diuretics may decrease the volume of CSF.A.Furosemide 1 to 2 mg/kg PO BIDB.Acetazolamide 0.1 mg/kg PO TID\nIII.Anticonvulsants may help control seizures.A.Phenobarbital 1 to 2 mg/kg PO BIDB.Potassium bromide (KBr) 20 to 30 mg/kg PO SID\nIV.Ventriculoperitoneal shunting of CSF to the abdominal cavity may be effective in some cases that are refractory to medical management, but complications include infections and shunt failure.V.Prognosis is guarded to poor in severely affected animals.VI.Animals with minimal clinical signs can often be managed long term.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition ::: Hydrocephalus ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Hydranencephaly is the congenital absence of a large portion of cerebrum in which cerebral cortex is absent and a fluid-filled, membranous sac takes its place (Summers et al., 1995).II.Porencephaly is a disorder in which single or multiple cavities within the cerebrum usually communicate with the lateral ventricles or the subarachnoid space (Summers et al., 1995).\n",
            "cite_spans": [
                {
                    "start": 163,
                    "end": 183,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 347,
                    "end": 367,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Definition ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Hydranencephaly in cats is associated with in utero vaccine-induced feline panleukopenia infection.II.Porencephaly may occur when in utero infection with feline panleukopenia virus occurs later in the period of fetal central nervous system (CNS) vulnerability, or from less virulent viruses.\n",
            "cite_spans": [],
            "section": "Causes ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The pathophysiology is not well understood.II.Parvoviral destruction of cerebral tissues is one potential mechanism.III.Hydranencephaly may arise from a fetal cerebrovascular accident that results in severe necrosis and resorption of cerebral tissue (Barone et al., 2000).\n",
            "cite_spans": [
                {
                    "start": 254,
                    "end": 273,
                    "mention": "Barone et al., 2000",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Pathophysiology ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs typically occur within several weeks of birth and are proportional to the extent of cerebral loss.II.Prosencephalic signs include blindness and behavioral abnormalities, such as compulsive behavior, indifference to surroundings, episodes of rage, and central blindness.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Presumptive diagnosis is based on clinical signs.II.Antemortem diagnosis can be made with MRI or CT.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Other congenital brain anomaliesIV.Degenerative encephalopathies\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Treatment is similar to that for hydrocephalus.II.The prognosis is guarded to poor.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition ::: Hydranencephaly and Porencephaly ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Lissencephaly is a congenital abnormality in which the cerebral hemispheres have a smooth surface and absence of normal development of gyri and sulci (Summers et al., 1995).II.Pachygyria is a condition in which the neocortex is much thicker than normal.III.In most cases the cause is unknown, but lissencephaly may be genetic in the Lhasa apso.\n",
            "cite_spans": [
                {
                    "start": 154,
                    "end": 174,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Lissencephaly and Pachygyria ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The normal laminar pattern of the neuronal cell body organization is disrupted.II.Bundles of white matter are randomly scattered throughout a thick cortex.III.There is no development of corona radiata.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Cause ::: Lissencephaly and Pachygyria ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Lissencephaly is most commonly observed in the Lhasa apso.II.Many dogs are difficult to house break but have relatively normal behavior.III.Prosencephalic signs include seizures starting around 1 year of age, behavioral changes, and visual deficits.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Lissencephaly and Pachygyria ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.MRI reveals an absence of cerebral sulci and gyri, pachygyria, and decreased organization of white mater.II.Definitive diagnosis is made by postmortem examination.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Lissencephaly and Pachygyria ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Other congenital brain anomalies, such as hydrocephalusIV.Degenerative encephalopathies\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Lissencephaly and Pachygyria ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No definitive treatment exists.II.Treat seizures symptomatically with anticonvulsants (see Chapter 22).III.Prognosis is guarded.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Lissencephaly and Pachygyria ::: CONGENITAL/DEVELOPMENTAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.These include developmental defects or malformations of the cerebellum.II.The cause of most malformations is unknown; however, some may be genetic in origin.III.Hypoplasia can result from in utero infections with feline and canine parvoviruses (Schatzberg et al., 2003).\n",
            "cite_spans": [
                {
                    "start": 248,
                    "end": 271,
                    "mention": "Schatzberg et al., 2003",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Definition and Causes ::: Definition and Causes ::: Definition and Causes ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.MalformationsA.Various forms of cerebellar agenesis and hypoplasia have been reported in dogs (Summers et al., 1995).B.A unique cerebellar malformation (Dandy-Walker syndrome) is characterized by a hypoplastic or aplastic cerebellum, cystic lesions of the caudal fossa or fourth ventricle, and hydrocephalus (Summers et al., 1995).\nII.HypoplasiaA.The external germinal layer of the cerebellum is destroyed in utero by a parvovirus, with hypoplasia of the granule layer and disorganization of the Purkinje cells.B.Viruses or their resulting inflammation may destroy previously differentiated Purkinje neurons and cerebellar parenchyma, causing atrophy of the cerebellum (de Lahunta 1983).\n\n",
            "cite_spans": [
                {
                    "start": 98,
                    "end": 118,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 312,
                    "end": 332,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 673,
                    "end": 688,
                    "mention": "de Lahunta 1983",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Pathophysiology ::: Definition and Causes ::: Definition and Causes ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs are present from the time the animal is able to walk and are usually nonprogressive.II.Signs include a wide stance, spastic-hypermetric gait (cerebellar ataxia), loss of balance, and intention tremors.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: Definition and Causes ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Presumptive diagnosis is based on clinical signs present at or soon after birth.II.Multiple animals in the litter may be affected.III.MRI may reveal a small cerebellum and increased amounts of CSF between the folia.IV.Definitive diagnosis is made by postmortem examination.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Definition and Causes ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Degenerative encephalopathiesII.Congenital cerebellar and abiotrophiesIII.Meningoencephalitis\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Definition and Causes ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No definitive treatment exists.II.Clinical signs are typically nonprogressive.III.Although signs persist, some animals make good pets.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Definition and Causes ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Occipital bone malformation and/or hypoplasia causes overcrowding of the caudal fossa and foramen magnum, obstruction of CSF, and syringohydromyelia.II.Syringohydromyelia is a fluid-filled cavity within the spinal cord (syrinx) and central canal (hydromyelia).\n",
            "cite_spans": [],
            "section": "Definition ::: Definition ::: Caudal Occipital Malformation and Syringohydromyelia ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Malformation of the occipital bone causes elongation and caudal displacement of the cerebellar vermis through the foramen magnum.II.The spinal cord is pushed caudally by the medulla and may have a kinked appearance.III.Occasionally, mild to moderate obstructive hydrocephalus is present.IV.Syringohydromyelia may develop secondarily, but the pathogenesis is uncertain.\n",
            "cite_spans": [],
            "section": "Causes and Pathophysiology ::: Definition ::: Caudal Occipital Malformation and Syringohydromyelia ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The Cavalier King Charles spaniel is overrepresented, but any breed may be affected.II.Affected animals range in age from 6 months to 10 years.III.Signs may manifest acutely or have an insidious course over months to years.IV.An unusual manifestation is the observation of paroxysmal involuntary flank or neck scratching in Cavalier King Charles spaniels.V.Spinal cord signs include cervical pain, cervical dystonia (torticollis), hyperesthesia, proprioceptive ataxia, abnormal postural reactions, varying degrees of paresis and hypermetria, and exercise intolerance.VI.Intracranial signs include seizures and deficits of cranial nerves VII and VIII.VII.Denervation of epaxial muscles and lesions in the dorsal tracks of the spinal cord can lead to muscle atrophy and scoliosis.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition ::: Caudal Occipital Malformation and Syringohydromyelia ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.MRI reveals varying degrees of ventriculomegaly, syringohydromyelia, compression of the cerebellum by the occipital bone, caudal displacement and herniation of the cerebellar vermis, and obstruction of the subarachnoid space at the foramen magnum.II.CSF analysis occasionally reveals a mild elevation in nucleated cells and total protein.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition ::: Caudal Occipital Malformation and Syringohydromyelia ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Intervertebral disc diseaseII.MeningoencephalitisIII.NeoplasiaIV.Atlantoaxial subluxation\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition ::: Caudal Occipital Malformation and Syringohydromyelia ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Prednisone 0.5 mg/kg PO QOD may control signs (Rusbridge et al., 2000).II.Surgical management (subtotal occipital craniectomy, dorsal laminectomy of first cervical vertebra and durotomy to relieve obstruction) may be indicated for dogs with progressive signs (Dewey et al., 2005).III.Prognosis is fair to good depending on the severity of clinical signs.\n",
            "cite_spans": [
                {
                    "start": 50,
                    "end": 72,
                    "mention": "Rusbridge et al., 2000",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 263,
                    "end": 281,
                    "mention": "Dewey et al., 2005",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Treatment and Monitoring ::: Definition ::: Caudal Occipital Malformation and Syringohydromyelia ::: CONGENITAL CEREBELLAR DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Many of these disorders (Table 23-1\n) are familial, hereditary, and cause degeneration of the CNS within the first few months of life (Summers et al., 1995).II.Abiotrophies are characterized by early or premature neuronal degeneration and cell death.A.They are typically associated with an inherent lack of vital trophic or nutritive factors.B.They are categorized by the location of the affected neurons.1.Cerebellar abiotrophies are the most common and affect cerebellar Purkinje cells.2.Multisystem neuronal abiotrophies affect neurons throughout the CNS.3.Motor neuron abiotrophies affect motor neurons and cause lower motor neuron signs, with marked denervation atrophy and debilitating muscle contractures (arthrogryposis).\n\nIII.Neuraxonal dystrophies are a group of inherited (often autosomal recessive) disorders characterized by axonal swellings (spheroids) in preterminal portions of axons and synaptic terminals.IV.Leukodystrophies (demyelinating disorders) are primary disorders of myelin synthesis.A.Leukodystrophies can involve CNS and peripheral nervous system (PNS) myelin.B.White matter involvement is usually regional, bilateral, and symmetrical.\nV.Hypomyelinogenesis is absent, delayed, or abnormal production of myelin.A.Histologically, oligodendrocytes are diminished in number or may be dysfunctional.B.An X-linked inheritance pattern is known or suspected.C.Other possible causes include in utero infections or intoxications.\nVI.Spongy degenerations are characterized by diffuse CNS vacuolation in the white and grey matter.VII.Axonopathies are characterized by diffuse CNS degeneration that result predominantly in encephalomyelopathies and neuropathies.A.A subset of these disorders (spinocerebellar degenerations) induces bilaterally symmetrical degeneration of ascending and descending tracts of the spinal cord.B.Despite lesions predominantly affecting the spinal cord, progressive cerebellar signs are seen clinically.\n\n",
            "cite_spans": [
                {
                    "start": 138,
                    "end": 158,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Definition and Causes ::: Definition and Causes ::: Neuronal Abiotrophies and Dystrophies ::: DEGENERATIVE DISORDERS",
            "ref_spans": [
                {
                    "start": 28,
                    "end": 38,
                    "mention": "Table 23-1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "\nI.With cerebellar abiotrophies, signs are noted in the first few weeks to months of life.A.Affected animals slowly develop progressive signs over months to years.B.Signs of cerebellar disease include a wide stance, spastic-hypermetric gait, loss of balance, intention tremors, and absent menace response.\nII.With neuraxonal dystrophies signs of spinal cord and cerebellar dysfunction occur.A.Lesions occur diffusely throughout the CNS, but spinal cord lesions predominate.B.Affected breeds include the rottweiler, Chihuahua, German shepherd dog, and domestic short-haired cat.\nIII.Hypomyelinating disorders are characterized by generalized tremors, especially in the pelvic limbs.A.They often abate with rest.B.Signs may resolve spontaneously or persist indefinitely.\n\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: Neuronal Abiotrophies and Dystrophies ::: DEGENERATIVE DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Diagnosis is suspected based on the signalment and clinical signs (see Table 23-1).II.MRI may be useful to demonstrate the distribution of lesions.III.Definitive diagnosis often requires postmortem examination.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Neuronal Abiotrophies and Dystrophies ::: DEGENERATIVE DISORDERS",
            "ref_spans": [
                {
                    "start": 74,
                    "end": 84,
                    "mention": "Table 23-1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "\nI.Disorders of intermediary metabolismII.Metabolic disordersIII.MeningoencephalitisIV.Neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Neuronal Abiotrophies and Dystrophies ::: DEGENERATIVE DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No definitive treatment exists for these degenerative disorders.II.Prognosis is variable and often poor for long-term survival.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Neuronal Abiotrophies and Dystrophies ::: DEGENERATIVE DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.These disorders are caused by inherited errors in intermediary metabolism that arise from abnormal or deficient enzyme systems (Summers et al., 1995).II.Some disorders are storage diseases.\n",
            "cite_spans": [
                {
                    "start": 131,
                    "end": 151,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Definition and Causes ::: Definition and Causes ::: Definition and Causes ::: DISORDERS OF INTERMEDIARY METABOLISM",
            "ref_spans": []
        },
        {
            "text": "\nI.Storage disorders are characterized by defective lysosomal enzymes that are catabolic or obligatory to cellular processes (Skelly and Franklin, 2002).A.Loss or dysfunction of a degradative enzyme results in the accumulation of specific substrates in the lysosomes that distend cells with stored products.B.Lesions may be multisystemic or limited to the CNS and/or PNS.C.Most storage diseases are autosomal recessive traits (Table 23-2\n).\nII.Disorders of intermediary metabolism affect enzyme systems that are not catabolic and do not result in stored substrate.A.They typically result in a unique, degenerative encephalopathy.B.Most are breed specific, with an autosomal recessive mode of inheritance (see Table 23-2).\n\n",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 151,
                    "mention": "Skelly and Franklin, 2002",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Pathophysiology ::: Definition and Causes ::: Definition and Causes ::: DISORDERS OF INTERMEDIARY METABOLISM",
            "ref_spans": [
                {
                    "start": 427,
                    "end": 437,
                    "mention": "Table 23-2",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 709,
                    "end": 719,
                    "mention": "Table 23-2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "\nI.Signs often reflect diffuse CNS involvement; however, cerebellar signs often predominate in storage diseases.II.See Table 23-2 for specific signs.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: Definition and Causes ::: DISORDERS OF INTERMEDIARY METABOLISM",
            "ref_spans": [
                {
                    "start": 119,
                    "end": 129,
                    "mention": "Table 23-2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "\nI.Diagnosis is often suspected based on signalment and clinical signs.II.DNA testing is available for some disorders (see Table 23-2).III.Diagnosis can be made through metabolite analysis of tissues or body fluids (urine or blood).\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Definition and Causes ::: DISORDERS OF INTERMEDIARY METABOLISM",
            "ref_spans": [
                {
                    "start": 123,
                    "end": 133,
                    "mention": "Table 23-2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "\nI.Congenital cerebellar disorders or cerebellar abiotrophy (storage disorders)II.MeningoencephalitisIII.NeoplasiaIV.Other degenerative encephalopathies\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Definition and Causes ::: DISORDERS OF INTERMEDIARY METABOLISM",
            "ref_spans": []
        },
        {
            "text": "\nI.Definitive treatment does not exist.II.Prognosis is variable and often poor for long-term survival.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Definition and Causes ::: DISORDERS OF INTERMEDIARY METABOLISM",
            "ref_spans": []
        },
        {
            "text": "\nI.Rickettsial disorders that can infect the brain include Rocky Mountain spotted fever (Rickettsia rickettsii), ehrlichiosis, and salmon poisoning (Greene, 2006).II.Rocky Mountain spotted fever is transmitted by Dermacentor andersoni, Dermacentor variabilis, and Amblyomma americanum ticks.III.Canine ehrlichiosis (Ehrlichia canis) is transmitted by the brown dog tick, Rhipicephalus sanguineus.IV.Salmon poisoning (Neorickettsia helminthoeca) is acquired by consumption of salmonid and other fish that carry the metacercaria of the fluke, Nanophyetus salmincola, which is the intermediate host.\n",
            "cite_spans": [
                {
                    "start": 149,
                    "end": 161,
                    "mention": "Greene, 2006",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Definition and Causes ::: Definition and Causes ::: Rickettsial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs arise from a nonsuppurative meningoencephalitis composed mostly of plasma cells.II.See Chapter 115 for systemic signs.III.Neurological signs reflect diffuse brain involvement.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: Rickettsial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF analysis reveals a mononuclear pleocytosis, with mild to moderate elevations in protein content.II.A complete blood count (CBC) may reveal thrombocytopenia, anemia, and leukopenia early in the course, followed by leukocytosis.III.Intracytoplasmic ehrlichia morulae are occasionally identified in blood and CSF mononuclear cells.IV.Definitive diagnosis is based on elevated serum titers, a four-fold rise in antibody titer, or positive polymerase chain reaction (PCR) assays (see Chapters 2 and 115).\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Rickettsial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Immune-mediated, noninfectious meningoencephalitisII.Other CNS infectionsIII.CNS neoplasia: lymphoma, metastatic neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Rickettsial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Doxycycline is given 5 to 10 mg/kg PO BID for 2 to 3 weeks.A.Antibiotics may be effective if initiated early in disease course.B.Dogs may respond dramatically within 1 to 2 days, but prognosis is guarded to poor when severe neurological deficits are present.\nII.Recovery may be prolonged, and residual neurological deficits are possible.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Rickettsial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Most mycotic infections are regional diseases that produce pyogranulomatous inflammation of the CNS and are treated similarly (Lavely and Lipsitz, 2005).A.Mycoses that may affect the CNS include Cryptococcus ghatti, Blastomyces dermatitidis, Histoplasma capsulatum, Coccidioides immitis, Aspergillus spp., phaeohyphomycosis, and hyalohyphomycosis.B.\nCryptococcus neoformans may be the most common CNS mycotic infection.\nII.Protothecosis is a rare CNS infection of dogs caused by the achlorophyllous algae, Prototheca wickerhamii and Prototheca zopfii.\n",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 154,
                    "mention": "Lavely and Lipsitz, 2005",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Definition and Causes ::: Definition and Causes ::: Mycotic and Algal Infections ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Cryptococcosis is typically acquired from the environment (e.g., pigeon droppings, dead trees) rather than directly from infected animals.II.The natural route of these infections is thought to be via the respiratory tract, with subsequent hematogenous and lymphogenous dissemination.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Causes ::: Mycotic and Algal Infections ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clinical signs may reflect a focal mass lesion or a diffuse, multifocal process.II.Signs also reflect the location of the lesions within the CNS and are variable.III.A profound elevation in intracranial pressure may cause severe changes in mentation (depression, stupor, coma).IV.Ocular and nasal discharge may be noted.V.See Chapter 111 for systemic signs.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: Mycotic and Algal Infections ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Diagnosis of cryptococcosis utilizes the latex agglutination test (LAT), which detects capsular antigen in serum, urine, or CSF.II.Serological testing for other agents is described in Chapters 2 and 111.III.CSF analysis sometimes reveals cryptococcal organisms by staining with India ink.A.Mononuclear, neutrophilic, or eosinophilic pleocytosis, and elevated protein levels are often present.B.Fungal culture of CSF is usually unrewarding.\nIV.MRI may show multiple inflammatory lesions that are hypointense on T1-weighted images and hyperintense on T2-weighted images, with multifocal parenchymal and leptomeningeal enhancement.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Mycotic and Algal Infections ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Immune-mediated, noninfectious meningoencephalitisII.Other CNS infectionsIII.CNS neoplasia: lymphoma, metastatic neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Mycotic and Algal Infections ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Amphotericin B may be given at 0.1 to 0.5 mg/kg IV, SC three times weekly.A.Animals treated with amphotericin B require weekly assessment of renal function, and it is contraindicated in animals with renal dysfunction.B.Liposome encapsulated preparations may be safer.\nII.Imidazole drugs may be tried alone or in conjunction with amphotericin.A.Fluconazole 5 to 15 mg/kg PO BID (preferred)B.Itraconazole 5 to 10 mg/kg PO BID\nIII.For cryptococcosis, the LAT is monitored monthly during treatment.A.Treatment is discontinued after two negative LAT tests are documented 1 month apart or 1 month after resolution of clinical signs.B.Treatment is often prolonged (3 to 12 months).C.Prognosis is guarded, especially for disseminated disease.\n\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Mycotic and Algal Infections ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Canine distemper virus is a multisystemic disease affecting the respiratory, alimentary, urogenital, ocular, and nervous systems in dogs.II.It is an RNA Morbillivirus of the family Paramyxoviridae.\n",
            "cite_spans": [],
            "section": "Definition and Cause ::: Definition and Cause ::: Canine Distemper Encephalomyelitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Several forms and stages of CNS disease exist (Summers et al., 1995).II.Lymphocytic meningoencephalomyelitis occurs during the first week of exposure.A.No neurological signs are seen during this phase.B.Infection may be self-limiting or may progress to affect either grey or white matter (more commonly).\nIII.Grey matter disease occurs approximately 1 week after initial infection.A.Typical sites of infection include the cerebral cortex, brainstem, and spinal cord.B.Grey matter disease typically occurs in puppies at 6 to 12 weeks of age; certain viral strains may cause disease in adult dogs.C.Postvaccinal disease (inadequately attenuated virus) can occur 7 to 10 days after vaccination and may result in severe brainstem lesions and death.D.Old-dog encephalitis is a rare, chronic form of the disease.E.Pathologic lesions include neuronal degeneration, gliosis, and eosinophilic inclusions in neurons and glial cells.\nIV.\nWhite matter disease is the most common form of infection and occurs approximately 1 month after initial infection.A.Demyelination is the hallmark finding.B.Lesions occur in sites that are adjacent to CSF path-ways (optic tracts, hippocampus, cerebellar peduncles, spinal cord).C.White matter lesions may be noninflammatory for 1 month, then progress to nonsuppurative meningitis and perivascular encephalitis.D.Inflammatory lesions ultimately become necrotizing.E.Eosinophilic inclusions can be observed in glial cells.\n\n",
            "cite_spans": [
                {
                    "start": 50,
                    "end": 70,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Pathophysiology ::: Definition and Cause ::: Canine Distemper Encephalomyelitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.With grey matter disease, signs reflect nonsuppurative meningitis.A.Seizures, stupor, hysteria, and ataxia can be observed.B.Dogs may die within 2 to 3 weeks, recover, or develop white matter disease.\nII.With white matter disease, signs are multifocal and variable.A.Commonly observed signs include cerebellovestibular ataxia and spinal cord paresis.B.Occasionally myoclonus develops of a single limb or the temporalis and/or masseter muscles.C.Some dogs die 4 to 5 weeks after initial infection, and some may recover with minimal CNS injury.D.Other dogs may have persistent CNS demyelination and nonsuppurative inflammation, with or without clinical signs.\n\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Canine Distemper Encephalomyelitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Presumptive diagnosis is based on history, signalment, vaccination status, and clinical signs, especially in nonvaccinated dogs.II.Immunofluorescent or immunocytochemical techniques can detect canine distemper viral antigen in brain sections and other tissues (mononuclear cells in blood, conjunctival or tracheal washes, foot pad biopsies).III.CSF analysis reveals moderate pleocytosis of mononuclear cells (lymphocytes, macrophages).A.Neutralizing antibody in CSF develops 2 to 3 weeks after onset of disease.B.The immunoglobulin G (IgG) index (calculated quotient of IgG and albumin levels in CSF compared to serum that detects intrathecal IgG synthesis) is elevated in most dogs except those with acute, noninflamma-tory distemper.\nIV.Reverse transcriptase PCR of urine, CSF, and conjunctival swabs may identify the virus.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Canine Distemper Encephalomyelitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Affected puppies: congenital and developmental diseasesII.Immune-mediated or noninfectious meningoencephalitisIII.Other causes of infectious meningoencephalitis: bacteria, parasites, protozoa, rickettsiaIV.Other viral CNS infectionsA.Borna disease (staggering disease), LaCrosse virusB.Canine herpesvirusC.RabiesD.Tickborne encephalitis virusE.Eastern equine encephalitis virusF.West Nile virus\nV.CNS neoplasia: lymphoma, metastatic disease\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Canine Distemper Encephalomyelitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No definitive treatment exists for the virus.II.Treatment is largely supportive (fluid therapy, nutritional support).III.Euthanasia is considered for dogs with progressive neurological signs that lead to incapacitation.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Canine Distemper Encephalomyelitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Feline infectious peritonitis (FIP) is a fatal, systemic immunopathologic disease caused by a feline coronavirus.II.Although meningitis may accompany the more acute form of peritoneal exudation, a second form affects the CNS and eye with little or no peritoneal involvement (Foley et al., 1998).\n",
            "cite_spans": [
                {
                    "start": 278,
                    "end": 296,
                    "mention": "Foley et al., 1998",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Feline Infectious Peritonitis Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The underlying pathogenesis involves a type III immune reaction and immune complex-induced vasculitis.II.This CNS infection is characterized by meningitis, ependymitis, and encephalomyelitis (Summers et al., 1995).III.The mesencephalic aqueduct may be obstructed, causing hydrocephalus and hydromyelia.IV.Focal brain or spinal cord lesions may also occur.\n",
            "cite_spans": [
                {
                    "start": 195,
                    "end": 215,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Pathophysiology ::: Definition and Cause ::: Feline Infectious Peritonitis Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs are usually nonspecific, but often include profound cerebellovestibular involvement.II.Signs from focal lesions reflect the site of the lesion.III.See Chapter 112 for systemic signs.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Feline Infectious Peritonitis Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Antemortem diagnosis is very challenging.II.CSF analysis reveals profound neutrophilic or mono-nuclear pleocytosis, with high elevations of protein.III.Identification of antibody titers in CSF is supportive.IV.Serum titers are difficult to interpret (see Chapter 112).V.Serum hypergammaglobulinemia and increased fibrino-gen levels may occur.VI.MRI may show marked dilation of the ventricular system and enhancement of ependymal (periventricular) surfaces and the choroid plexus.VII.Definitive diagnosis requires histopathology.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Feline Infectious Peritonitis Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Congenital or developmental diseasesII.CNS neoplasia: lymphosarcomaIII.Other viral diseases: feline immunodeficiency virus, Borna diseaseIV.\nBacterial meningoencephalitisV.Toxoplasmosis\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Feline Infectious Peritonitis Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Because no definitive treatment exists, supportive care (fluid therapy, nutritional support) may be tried.II.Prednisone 2 to 4 mg/kg PO SID to BID may provide palliative relief.III.The prognosis is grave for long-term survival.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Feline Infectious Peritonitis Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is inflammation of the brain and/or meninges from aerobic or anaerobic bacterial infections.II.Organisms that can infect the CNS include Pasteurella, Staphylococcus, Actinomyces, Nocardia, Streptococcus, and Klebsiella spp., and Eschericia coli.\n",
            "cite_spans": [],
            "section": "Definition and Causes ::: Definition and Causes ::: Bacterial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.A variety of mechanisms allow bacterial entry into the CNS.A.Hematogenous spread from distant foci: lung abscess, vegetative endocarditis, urinary tract infectionB.Direct extension from nasal and paranasal sinuses, ears, and eyesC.Secondary to trauma and wound contamination (bite wound)D.Meningeal spread along nerve rootsE.Contaminated surgical instruments: spinal needles\nII.Organisms usually disseminate through CSF pathways and produce meningitis and microabscesses of the brain and spinal cord.III.Formation of inflammatory cytokines and tumor necrosis factor by monocytes and neural cells leads to altered blood-brain barrier permeability, recruitment of neutrophils, and purulent exudates in the subarachnoid space.IV.Vasculitis leads to vasogenic brain edema.V.Toxic oxygen metabolites released from degranulating leukocytes also cause cytotoxic brain edema.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Causes ::: Bacterial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clinical signs begin acutely.II.Systemic signs include fever, vomiting, bradycardia, ano-rexia, shock, and hypotension.III.Neurological signs consist of hyperesthesia, cervical pain and rigidity (common), seizures (occasionally), and cranial nerve deficits (Radaelli and Platt, 2002).\n",
            "cite_spans": [
                {
                    "start": 261,
                    "end": 285,
                    "mention": "Radaelli and Platt, 2002",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Clinical Signs ::: Definition and Causes ::: Bacterial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF analysis typically shows a profound neutrophilic pleocytosis and protein elevation.A.Organisms sometimes may be seen on CSF cytology.B.Bacterial culture of CSF (aerobic and anaerobic) provides a definitive diagnosis, but negative cultures do not rule out the disease.\nII.Blood and urine cultures may yield a pathogenic organism.III.A CBC may reveal a neutrophilic leukocytosis and left shift.IV.MRI and CT can show meningeal, brain and/or ventricular enhancement, as well as abscessation.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Bacterial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Immune-mediated meningoencephalitis, especially steroid-responsive meningitis/arteritisII.Intervertebral disc diseaseIII.Other CNS infectionsIV.CNS neoplasia: lymphoma, metastatic neoplasiaV.Systemic bacterial infections\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Bacterial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Preferred antibiotic therapy is based on culture results and is continued for several weeks after clinical signs have resolved.II.Empirical treatment choices in dogs are as follows:A.Chloramphenicol 50 mg/kg IV, IM, SC, PO BIDB.Metronidazole 10 to 15 mg/kg PO TIDC.Enrofloxacin 10 mg/kg IV, PO SIDD.Azithromycin 5 to 10 mg/kg PO SIDE.Trimethoprim-sulfonamide 15 to 30 mg/kg PO BID\nIII.Corticosteroids are generally contraindicated, but antiinflammatory doses may be beneficial upon initiation of treatment.IV.Prognosis is guarded.A.Death is common even if appropriate therapy is administered.B.Relapses are frequently encountered.\n\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Bacterial Meningoencephalitis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Toxoplasmosis may be the most common protozoa to affect the CNS in dogs and cats.II.The causative agent is Toxoplasma gondii.\n\n",
            "cite_spans": [],
            "section": "Definition and Cause ::: Definition and Cause ::: Toxoplasmosis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Organisms may form cysts in the CNS and in the skeletal and heart muscles.II.Parasites are mainly intracellular, and subclinical infection may persist for life.III.Activation may occur with severe immunosuppression, especially from viral infections.IV.Nonsuppurative (focal or multifocal) necrotizing meningoencephalomyelitis occurs in the CNS, whereas radiculitis and myositis develop in the PNS.V.Chorioretinitis commonly accompanies CNS lesions.VI.Lesions may also occur in lungs, liver, spleen, and lymph nodes.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Cause ::: Toxoplasmosis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The disease most commonly affects animals <1 year of age or animals that are immunocompromised.II.Clinical signs relate to either focal (granulomas) or multifocal CNS disease.III.\nPossible signs include hyperexcitability, depression, intention tremors, paresis, paralysis, head tilt, and seizures.IV.Spinal cord signs are more common in cats.V.See Chapter 116 for systemic signs.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Toxoplasmosis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Definitive diagnosis is often difficult to establish (see Chapter 116).II.CSF analysis may demonstrate a mononuclear, neutrophilic, or eosinophilic pleocytosis, with elevated protein levels.III.PCR may reveal the presence of the organism in CSF, muscle, or liver biopsies.IV.Electromyography (EMG) may show abnormal spontaneous activity in animals with muscle and nerve involve-ment, and nerve conduction velocities may be decreased in animals with nerve involvement.V.MRI or CT may reveal focal or multifocal CNS lesions.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Toxoplasmosis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.DogsA.\nNeospora caninum\n1.Most often affects dogs <2 years of age2.Predilection for lumbosacral nerve roots (radiculitis, neuritis, see Chapter 24)3.May cause encephalitis (especially cerebellitis) in adult dogs\nB.Sarcocystosis, encephalitozoonosis, trypanosomiasisC.Acanthamebiasis, babesiosisD.LeishmaniasisE.Autoimmune, bacterial, viral meningoencephalitisF.Neoplasia: lymphosarcoma, histiocytic tumors\nII.CatsA.FIPB.Neoplasia: lymphosarcomaC.Borna diseaseD.Bacterial meningoencephalitis\n\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Toxoplasmosis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clindamycin is the drug of choice and is given at 10 to 20 mg/kg PO, IM BID for 3 to 6 weeks.II.Alternatively, trimethoprim-sulfonamide (15 to 20 mg/kg PO BID) is combined with pyrimethamine at 1 mg/kg PO SID for 4 to 8 weeks.III.Prognosis is guarded with CNS involvement, but some animals survive with minimal residual neurological deficits.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Toxoplasmosis ::: INFECTIOUS DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Granulomatous meningoencephalomyelitis (GME) is an idiopathic (mononuclear) meningoencephalomyelitis that most commonly occurs in young to middle-age dogs.II.GME is thought to be an immune-mediated (delayed-type hypersensitivity) disease based on the presence of major histocompatibility complex class II and cluster differentiation (CD3) antigen-positive lymphocytes (Kipar et al., 1998).\n",
            "cite_spans": [
                {
                    "start": 372,
                    "end": 390,
                    "mention": "Kipar et al., 1998",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Granulomatous Meningoencephalomyelitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Three morphological forms exist, namely disseminated, focal, and ocular disease (Summers et al., 1995).II.Lesions consist of perivascular, concentric proliferations of inflammatory cells predominantly in the white matter.III.Perivascular cellular accumulations consist of lymphocytes, plasma cells, and mononuclear cells.\n",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 104,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Pathophysiology ::: Definition and Cause ::: Granulomatous Meningoencephalomyelitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Onset ranges from 9 months to 10 years of age.II.Signs may be acute, rapidly progressive and fatal, or chronic and insidious.III.The focal form of GME results in focal deficits, whereas the disseminated form causes multifocal signs.IV.Neurological signs reflect lesion location and distribution.A.Brainstem (varying degrees of depression and spastic tetraparesis, vestibular ataxia, head tilt, abnormal nystagmus) and cerebellar signs are most common.B.Prosencephalic signs include seizures, depression, circling, and visual deficits.C.The ocular form causes visual deficits, anisocoria, and abnormalities in pupillary light reflexes.\nV.A fever is often present.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Granulomatous Meningoencephalomyelitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The CSF usually reveals a mild to severe pleocytosis of monocytes and lymphocytes, with mild protein elevation.II.MRI and CT may reveal multifocal lesions, predominantly in the white matter of the CNS.III.Definitive diagnosis requires histopathology.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Granulomatous Meningoencephalomyelitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Necrotizing meningoencephalitisII.Necrotizing leukoencephalitisIII.Infectious meningoencephalitisIV.CNS neoplasia: lymphoma, metastatic neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Granulomatous Meningoencephalomyelitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Immunosuppression is the primary therapy.II.Prednisone is given at 1.0 to 3.0 mg/kg PO BID for 1 month, then gradually tapered over several months to 0.5 mg/kg PO SID to QOD.III.Additional drugs may allow a reduction in prednisone and ameliorate its side effects.A.Cytosine arabinoside 50 mg/m2 SC BID for 2 days, repeated every 3 weeks (Zarfoss et al., 2006)B.Cyclosporine 5 to 10 mg/kg PO BID (Adamo and O'Brien, 2004)C.Others: leflunomide, procarbazine, CCNU (lomustine)\nIV.Radiation therapy may be beneficial for the focal form.V.GME is rarely cured and often requires lifelong therapy to control the inflammation.\n",
            "cite_spans": [
                {
                    "start": 341,
                    "end": 361,
                    "mention": "Zarfoss et al., 2006",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 399,
                    "end": 422,
                    "mention": "Adamo and O'Brien, 2004",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Granulomatous Meningoencephalomyelitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is an idiopathic meningoencephalitis of young pugs, Maltese, Shih tzus, and occasionally other small-breed dogs (Cordy and Holliday, 1989; Stalis et al., 1995).II.It is presumed to be an immune-mediated disease.\n",
            "cite_spans": [
                {
                    "start": 119,
                    "end": 143,
                    "mention": "Cordy and Holliday, 1989",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 145,
                    "end": 164,
                    "mention": "Stalis et al., 1995",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Necrotizing Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Lesions consist of nonsuppurative meningoencephalitis and mild cerebral necrosis.II.It typically affects the cerebral hemispheres, with inflammation extending from the leptomeninges through the cortex and into the corona radiata.III.This pattern leads to a loss of demarcation between cortical grey and white matter in the brain.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Cause ::: Necrotizing Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Onset ranges from 9 months to 4 years of age.II.Signs may be rapidly progressive and fatal.III.Signs consist of prosencephalic signs, such as seizures, depression, circling, and visual deficits.IV.Motor and sensory problems (ataxia, paresis), brainstem and cerebellar signs are also possible.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Necrotizing Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF analysis shows a moderate to severe pleocytosis composed of monocytes and lymphocytes, with mild protein elevation.II.MRI findings mirror the topography of the histopathologic lesions.III.MRI typically demonstrates multifocal lesions in the superficial cortical grey matter at the junction of the cerebrum and leptomeninges.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Necrotizing Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Granulomatous meningoencephalomyelitisII.Necrotizing leukoencephalitisIII.Infectious meningoencephalitisIV.CNS neoplasia: lymphoma, metastatic neoplasiaV.Metabolic, toxic encephalopathiesVI.Other causes of seizures: see Chapter 22\n\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Necrotizing Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Immunosuppression is the primary therapy and is similar to that for GME.II.The prognosis is grave.III.If a response is seen to immunosuppression, lifelong therapy is necessary to control the inflammation.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Necrotizing Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is an idiopathic (mononuclear) meningoencephalitis of young Yorkshire terriers, Chihuahuas, and occasionally other small-breed dogs (Tipold et al., 1993).II.It is presumed to be an immune-mediated disease.\n",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 158,
                    "mention": "Tipold et al., 1993",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Necrotizing Leukoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Lesions consist of nonsuppurative meningoencephalitis and moderate to severe cerebral necrosis.II.Gross cavitations occur in periventricular cerebral and diencephalic (thalamocortical) white matter.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Cause ::: Necrotizing Leukoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Onset is from 1 to 5 years of age.II.The clinical course is slowly progressive, usually over many weeks to months.III.Clinical signs reflect caudal brainstem or prosencephalic lesions.IV.Brainstem signs often predominate and include varying degrees of depression, spastic tetraparesis, vestibular ataxia, head tilt, and abnormal nystagmus.V.Prosencephalic signs consist of seizures, propulsive activity, and visual deficits.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Necrotizing Leukoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The CSF analysis usually reveals a moderate to severe pleocytosis of monocytes and lymphocytes and a mild protein elevation.II.MRI and CT may show multifocal cavitating lesions predominantly in deep white matter.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Necrotizing Leukoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Granulomatous meningoencephalomyelitisII.Necrotizing meningoencephalitisIII.Infectious meningoencephalitisIV.CNS neoplasia: lymphoma, metastatic neoplasiaV.Metabolic or toxic encephalopathiesVI.Other causes of seizures: see Chapter 22\n\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Necrotizing Leukoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Immunosuppression is the mainstay of therapy (see under GME).II.The prognosis is grave and therapy may be life-long.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Necrotizing Leukoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The disease is a neutrophilic meningitis of young dogs that is characterized by episodes of severe pain, depression, and fever (Cizinauskas et al., 2000).II.It is presumed to be immune-mediated.III.It is also known as steroid-responsive (or sterile) meningitis-arteritis, immune-mediated meningitis, Beagle pain syndrome, systemic necrotizing vasculitis, and juvenile polyarteritis syndrome.\n\n",
            "cite_spans": [
                {
                    "start": 131,
                    "end": 155,
                    "mention": "Cizinauskas et al., 2000",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Canine Meningeal Polyarteritis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Inflammation occurs in the leptomeningeal arteries.II.Leptomeningeal vascular lesions may be accompanied by lymphocytic thyroiditis, amyloidosis (splenic, hepatic, renal), or polyarthritis (Webb et al., 2002).\n",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 210,
                    "mention": "Webb et al., 2002",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Pathophysiology ::: Definition and Cause ::: Canine Meningeal Polyarteritis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Affected dogs range in age from 6 months to a few years.II.It affects the beagle, Bernese mountain dog, boxer, German short-haired pointer, and is sporadically reported in other breeds.III.The predominant clinical signs are profound neck pain, depression, anorexia, and fever.IV.Occasionally, ataxia and varying degrees of paresis are also present (see Chapter 24).V.The clinical course is typically acute in onset.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Canine Meningeal Polyarteritis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Signalment and clinical signs are suggestive.II.CSF analysis reveals the following:A.CSF has a severe neutrophilic pleocytosis, with excessive protein and phagocytosed red blood cells (RBCs).B.Neutrophils in CSF do not show toxic changes, and intracellular bacteria are not observed.C.CSF aerobic and anaerobic bacterial cultures are negative.D.Consistent elevation of CSF and serum immunoglobulin (Ig) A concentrations occur.\nIII.Occasionally peripheral neutrophilia with a left shift and an elevated serum \u03b12-globulin fraction are found.IV.CT or MRI may demonstrate contrast enhancement of the meninges, spinal cord, or brain.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Canine Meningeal Polyarteritis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Intervertebral disc diseaseII.Bacterial meningoencephalitisIII.Other immune-mediated meningoencephalitidesIV.CNS neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Canine Meningeal Polyarteritis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Long-term immunosuppression is achieved with prednisone at 1 to 2 mg/kg PO BID, then tapered monthly over 6 months.II.In refractory cases, azathioprine (1.5 mg/kg PO SID to QOD) may be added and eventually alternated with prednisone QOD.III.Prognosis is guarded to favorable; recurrences are common.IV.Monitor for recurrences, and consider repeating the CSF analysis if clinical signs persist.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Canine Meningeal Polyarteritis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Eosinophilic meningoencephalitis is an uncommon disease, primarily of rottweilers and golden retrievers, that is characterized by severe, multifocal neurological signs (Smith-Maxie et al., 1989; Schultze et al., 1986).II.It is presumed to be an immune-mediated disease.\n",
            "cite_spans": [
                {
                    "start": 172,
                    "end": 196,
                    "mention": "Smith-Maxie et al., 1989",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 198,
                    "end": 219,
                    "mention": "Schultze et al., 1986",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Eosinophilic Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Prosencephalic signs consist of behavioral and mentation changes, circling, pacing, head pressing, blindness, and generalized or partial seizures.II.Brainstem signs include episodic collapse, facial paralysis, absent gag reflex, reduced pupillary light reflexes, torticollis, and varying degrees of ataxia and incoordination.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Eosinophilic Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF analysis shows variable pleocytosis, with 21% to 98% eosinophils, and elevated protein content.II.Mild to moderate systemic eosinophilia may be observed.III.Serology for infectious diseases is negative.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Eosinophilic Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Other CNS infections: primary protozoal, fungal, parasiticII.Other noninfectious meningoencephalitidesIII.CNS neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Eosinophilic Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Prednisone therapy (and possibly additional immunosuppressive agents) is instituted similar to that for GME.II.Prognosis is favorable to guarded.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Eosinophilic Meningoencephalitis ::: NONINFECTIOUS INFLAMMATORY DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Idiopathic tremor syndrome (shaker dog disease) is a meningoencephalitis of young, small, white dogs (de Lahunta, 1983).II.Occasionally, dogs with pigmented coats are affected.III.The exact pathogenesis remains uncertain, although it may be immune-mediated.IV.Mild lymphoplasmacytic meningoencephalitis is the predominant lesion.\n",
            "cite_spans": [
                {
                    "start": 105,
                    "end": 121,
                    "mention": "de Lahunta, 1983",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Idiopathic Tremor Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It most commonly affects Maltese and West Highland white terriers.II.Other affected breeds include the bichon fris\u00e9, Spitz, samoyed, beagle, dachshund, and Yorkshire terrier.III.The predominant clinical sign is continuous, whole-body tremors that worsen with exercise, stress, and excitement, but disappear with sleep.IV.Neurological examination often is normal, with the exception of generalized tremors.V.When present, neurological signs may include absent menace response, spontaneous nystagmus, poor to absent oculocephalic reflexes (physiological nystagmus), vestibular or cerebellar ataxia, head tilt, varying degrees of paresis, and seizures.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Idiopathic Tremor Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF analysis reveals mild lymphocytic pleocytosis, with normal or mildly elevated protein levels.II.MRI typically is normal, but may disclose symmetrical ventricular enlargement in some dogs.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Idiopathic Tremor Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Dysmyelinogenic disorders\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Idiopathic Tremor Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Prednisone is administered at 1 to 2 mg/kg PO SID for 4 weeks, then tapered to 0.5 to 1 mg/kg PO SID for 2 weeks, then to QOD for 2 weeks, then to every 72 hours for 4 weeks.II.Diazepam 0.25 mg/kg PO BID to TID or propanolol 1 mg/kg PO TID may be beneficial in refractory cases.III.Prognosis is favorable, with tremors usually decreasing by the end of the first week of therapy.IV.Relapses can occur and may require additional immunosuppressive therapy (e.g., azathioprine).\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Idiopathic Tremor Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is an idiopathic disorder characterized by acute onset of trigeminal nerve paresis or paralysis (de Lahunta, 1983).II.It may be an immune-mediated condition.\n",
            "cite_spans": [
                {
                    "start": 103,
                    "end": 119,
                    "mention": "de Lahunta, 1983",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Trigeminal Neuropathy ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clinical signs include an acute onset of jaw paresis or paralysis with an inability to close the mouth, drooling, and difficult prehension of food and water.II.Trigeminal sensory deficits are common.III.Horner's syndrome (from effects on postganglionic sympathetic fibers incorporated in segments of the ophthalmic branch of the trigeminal nerve) is occasionally seen.IV.Occasionally, the facial nerve is also involved.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Trigeminal Neuropathy ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.EMG of the muscles of mastication is abnormal.II.CSF analysis may reveal a mild mononuclear pleocytosis, often with normal or mildly elevated protein content.III.Definitive diagnosis of trigeminal neuropathy requires biopsy of the trigeminal nerve, but it is rarely done.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Trigeminal Neuropathy ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Lymphoma infiltrating the trigeminal nervesII.PolyradiculoneuritisIII.RabiesIV.Masticatory muscle myositis\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Trigeminal Neuropathy ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The condition is often self-limiting, with recovery occurring over 3 to 4 weeks to several months.II.Corticosteroids do not seem to affect the clinical course.III.Fluid and nutritional support may be necessary for animals unable to eat and drink on their own.IV.The severity of muscle atrophy, clinical course, and recovery depends upon the extent of axonal degeneration.V.Prognosis is favorable in most cases, but can be guarded in severely affected animals.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Trigeminal Neuropathy ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is a disorder of mature dogs and cats that is character-ized by facial palsy or paralysis (Kern and Erb, 1987).II.The cause is unknown.\n",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 115,
                    "mention": "Kern and Erb, 1987",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Idiopathic Facial Nerve Paralysis ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Predisposition exists in the American cocker spaniel, Pembroke Welsh corgi, boxer, English setter, and domestic long-haired cat.II.Clinical signs include ear drooping, commissural paralysis of the lip, sialosis, deviation of the nose away from the affected side, and collection of food on the paralyzed side of the mouth.III.Menace response and palpebral reflexes are absent ipsilaterally.IV.Facial paralysis is usually unilateral, but may be bilateral in some animals.V.Horner's syndrome is not seen.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Idiopathic Facial Nerve Paralysis ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Diagnosis is often presumptive, based on clinical signs and exclusion of other disorders.II.EMG may reveal spontaneous denervation potentials in superficial facial muscles.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Idiopathic Facial Nerve Paralysis ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Polyradiculoneuritis (coonhound paralysis)II.Endocrine disorders: hypothyroidism, insulinomaIII.Laryngeal paralysis syndromeIV.Myasthenia gravis, botulismV.Trauma near the stylomastoid foramen or in conjunction with petrosal bone fractureVI.Middle ear infection, neoplasiaVII.Surgery of the external or middle ear, or side of the faceVIII.Extracranial tumors\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Idiopathic Facial Nerve Paralysis ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Application of ophthalmic lubricants helps prevent corneal drying.II.Prognosis for a complete return to function is guarded.III.Chronic lip paralysis may result in permanent contracture, and the inability to close the eyelids often leads to keratitis.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Idiopathic Facial Nerve Paralysis ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.It is an acute disorder that occurs in cats of all ages and in older dogs (de Lahunta, 1983).II.Mechanism and cause are unknown.III.Most feline cases (80%) occur in the summer (Burke et al., 1985).\n",
            "cite_spans": [
                {
                    "start": 78,
                    "end": 94,
                    "mention": "de Lahunta, 1983",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 180,
                    "end": 198,
                    "mention": "Burke et al., 1985",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Peripheral Vestibular Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clinical signs occur acutely.II.Only signs of peripheral vestibular dysfunction (no evidence of facial nerve paralysis or Horner's syndrome) are present.III.\nSigns include head tilt, asymmetrical ataxia, and horizontal or rotatory nystagmus with the fast phase directed away from the head tilt.IV.More severe signs of falling, rolling, and vomiting (especially in dogs) are seen occasionally.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Peripheral Vestibular Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Presumptive diagnosis is based on signalment, history, clinical signs, and exclusion of other etiologies.II.Absence of otoscopic and radiographic abnormalities of the middle ear is supportive.III.MRI or CT scan is normal.IV.CSF analysis is normal.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Peripheral Vestibular Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Otitis media/internaII.NeoplasiaIII.Cerebrovascular accident of brainstem\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Peripheral Vestibular Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Supportive care is administered, as needed.II.Affected animal tends to stabilize in a few days and improve gradually over several weeks.III.Prognosis for spontaneous remission is good; however, residual deficits (e.g., mild head tilt) may occur.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Peripheral Vestibular Syndrome ::: IDIOPATHIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Aberrant migration of parasite larvae through the CNS results in parenchymal damage and neurological signs (Braund, 2005).II.It is also known as cerebral larval migrans.\n\n",
            "cite_spans": [
                {
                    "start": 111,
                    "end": 123,
                    "mention": "Braund, 2005",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Definition ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.\nToxocara canis\nII.\nAncylostoma caninum\nIII.\nAngiostrongylus cantonensis\nIV.\nDirofilaria immitis\nV.\nAngiostrongylus vasorum\nVI.\nCysticercus cellulosae\nVII.\nBaylisascaris procyonis\nVIII.\nCoenurus serialis\n\n",
            "cite_spans": [],
            "section": "Causes ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Migrating larvae damage neural tissue by two mechanisms.II.Necrosis can occur in tissue along the migratory pathway.III.Migrating larvae evoke an inflammatory response, which causes ischemia, edema, and toxic injury to myelin, axons, and neurons.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clinical signs are acute in onset and rapidly progressive.II.Signs reflect the location of the migratory pathway.A.Prosencephalon signs include blindness, circling, behavioral changes, seizures, and postural reaction deficits.B.Brainstem signs include varying degrees of ataxia and paresis, changes in mentation, cranial nerve deficits, head tilt, and spontaneous nystagmus.C.Cerebellar signs include a wide stance; a spastic, hypermetric gait; loss of balance; intention tremors; and absent menace response.\nIII.Neurological signs may reflect focal or multifocal disease.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF is characterized by an eosinophilic or neutrophilic pleocytosis, and protein elevation.II.A positive test for D. immitis is suggestive.III.Definitive diagnosis requires histological demonstration of the parasite within the CNS.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Infectious meningoencephalitisII.Eosinophilic meningoencephalomyelitisIII.GMEIV.Neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No successful therapy to dateII.Guarded prognosis\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition ::: Parasitic Encephalomyelitis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "Aberrant migration of Cuterebra spp. larvae can occur within the CNS of cats and dogs (rarely) (Glass et al., 1998).",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 114,
                    "mention": "Glass et al., 1998",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Definition and Cause ::: Definition and Cause ::: Intracranial Myiasis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Larvae may migrate through the nose, ethmoids, and cribriform plate and enter the brain through the olfactory lobe.II.Alternatively, larvae can migrate through foramina of the skull, travel through the external and middle ear, penetrate the mastoid region, invade venous sinuses and meninges, or enter hematogenously after penetrating a large vessel.III.Microscopic necrosis of the brain occurs secondary to ischemia.IV.Lesions are usually unilateral in regions supplied by the middle cerebral artery (see Cerebral Vascular Disease).V.It is hypothesized that the larvae produce a toxin that causes vasospasm and cerebral infarction and may cause superficial laminar cerebrocortical necrosis (Williams et al., 1998).\n",
            "cite_spans": [
                {
                    "start": 695,
                    "end": 716,
                    "mention": "Williams et al., 1998",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Pathophysiology ::: Definition and Cause ::: Intracranial Myiasis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Animals are often affected in summer months, when adult flies deposit their ova.II.Typically outdoor cats (rarely dogs) are affected.III.Many cats have signs consistent with upper respiratory disease (especially sneezing) before the appearance of neurological signs.IV.Neurological signs are peracute in onset.V.Prosencephalic signs, including unilateral postural reaction deficits, unilateral facial (and occasionally whole-body) hypalgesia, and a menace deficit with a dilated, nonresponsive pupil from involvement of the optic tracts are noted.VI.Seizures and profound behavioral and mentation changes are often present.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Cause ::: Intracranial Myiasis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.CSF analysis may be normal or show a mild to moderate pleocytosis (neutrophilic, mononuclear, or occasionally eosinophilic), with mild protein elevation.II.MRI may reveal the migratory path of the larvae, cerebrocortical lesions, and evidence of a focal or regional infarction.III.Definitive diagnosis requires histopathology.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Cause ::: Intracranial Myiasis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Other infectious or parasitic meningoencephalitisII.Eosinophilic meningoencephalitisIII.Neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Cause ::: Intracranial Myiasis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.The following may be beneficial, but controlled studies have not been done.A.Pretreat with diphenhydramine 4 mg/kg IM.B.Give ivermectin 400 \u03bcg/kg SC and dexamethasone 0.1 mg/kg IV.C.Repeat the treatment 24 to 48 hours later.\nII.A third-generation cephalosporin, trimethoprim-sulfa drug, or metronidazole may be given to prevent bacterial infection associated with larval migration.III.Although prognosis is guarded; some cats may recover over weeks to months with residual neurological deficits.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Cause ::: Intracranial Myiasis ::: PARASITIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.These include disturbances in cerebral function from metabolic derangements or toxicoses that usually manifest as diffuse prosencephalic signs.II.See Table 23-3\nfor a list of causes.\n",
            "cite_spans": [],
            "section": "Definition and Causes ::: Definition and Causes ::: General Information ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": [
                {
                    "start": 153,
                    "end": 163,
                    "mention": "Table 23-3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "\nI.Energy deprivation leads to alterations in neuronal resting membrane potentials, and may disrupt neurotransmitter function and metabolism.II.Certain toxins and metabolic abnormalities may interfere with energy metabolism in the brain, potentially causing neuronal death.III.Electrolyte imbalances may alter neuronal excitability and neurotransmission.IV.Changes in serum osmolality and water content lead to altered osmotic balance in neural cells, which may cause either brain cell swelling (edema) or dehydration.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Causes ::: General Information ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic encephalopathies typically cause diffuse, symmetrical prosencephalic signs, such as seizures, altered mentation (confusion, disorientation, dementia, pacing, head pressing), circling, and altered consciousness (obtundation, stupor, coma).II.Onset may be acute or chronic, and signs may wax and wane.III.Motor signs include tremors, myoclonus, and varying degrees of paresis/paralysis.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: General Information ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Other evidence of metabolic disturbances may be identified from the history or the physical examination.II.A minimum laboratory database includes a complete blood count, biochemistry profile, and urinalysis.III.Other diagnostic tests are considered based on initial findings.A.Serum bile acidsB.Blood gas analysisC.Measurement of serum osmolalityD.Endocrine function testsE.Cardiopulmonary function tests: electrocardiography, blood pressure measurement, radiography, echocardiographyF.Abdominal radiography and ultrasonography\n\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: General Information ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Degenerative encephalopathiesII.MeningoencephalitisIII.NeoplasiaIV.Brain malformations\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: General Information ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Ensure an adequate airway; support breathing and circulation if the animal is comatose.II.Correct the underlying metabolic disturbance.III.Consider anticonvulsants for seizures.IV.Take care when treating seizures in animals with hepatic insufficiency, because they are unable to metabolize many anticonvulsants.A.Give diazepam (0.5 mg/kg IV), but reduce the dosage if hepatic encephalopathy is a primary concern.B.Give phenobarbital initially at 2.0 mg/kg PO, IV, IM BID, with caution.1.Metabolism may be compromised with hepatic dysfunction.2.Acidosis causes increased penetration of barbiturates into the brain.\nC.Seizures may be difficult to control until the under-lying metabolic imbalance is corrected.\nV.Administer dextrose if hypoglycemia is identified (see Chapter 46).VI.In most cases, neurological signs resolve once the metabolic disturbance is corrected.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: General Information ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "See Chapter 37.",
            "cite_spans": [],
            "section": "Hepatic Encephalopathy ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Cerebrovascular disease refers to conditions that result in brain ischemia, infarction, or hemorrhage.II.These conditions include the following:A.Cerebrovascular accidents: thromboembolism and infarction, hemorrhage (Garosi et al., 2005)B.Vascular anomalies: aneurysm, hamartomaC.Cerebral arteriosclerosis secondary to severe hypothyroidismD.MeningoencephalitisE.Intravascular neoplasms: lymphoma\n\n",
            "cite_spans": [
                {
                    "start": 220,
                    "end": 239,
                    "mention": "Garosi et al., 2005",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Definition ::: Definition ::: Cerebrovascular Disease ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Cerebral ischemia occurs as a result of insufficient blood supply to the brain.A.Dogs may have transient ischemic attacks, possibly from vasospasm.1.Attacks are often of unknown etiology.2.Occasionally they are associated with hypertension.\nB.Feline ischemic encephalopathy (FIE) occurs in the late summer, most commonly in eastern North America.1.Aberrant migration of Cuterebra spp. larva is thought to be the primary cause (Glass et al., 1998).2.It is hypothesized that a toxin from the larva causes vasospasm (of the middle cerebral artery), resulting in a unilateral ischemic brain lesion (Williams et al., 1998).\n\nII.Hypoperfusion of the brain is associated with atherothrombosis or embolism.A.With atherothrombosis, a localized thrombus forms and disrupts blood flow, with subsequent ischemia and/or infarction.B.With embolization, an artery is suddenly occluded, usually by a thrombus that arises from a distant site, such as in the heart (blood clot) or a neoplasm (e.g., neoplastic cells from hemangiosarcoma).\nIII.Systemic hypoperfusion causes a decrease in cerebral blood flow and can lead to infarction in the border zones between major cerebral arteries (watershed infarction).IV.Impaired blood supply to the brain results in a decline in tissue oxygen levels (stagnant hypoxia), which cause brain ischemia.\n",
            "cite_spans": [
                {
                    "start": 430,
                    "end": 448,
                    "mention": "Glass et al., 1998",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 598,
                    "end": 619,
                    "mention": "Williams et al., 1998",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Causes and Pathophysiology ::: Definition ::: Cerebrovascular Disease ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Clinical signs are peracute and may be followed by progressive recovery over days to weeks.II.Clinical signs reflect the location of brain infarction.III.Although gait deficits are not typically seen with prosencephalic lesions, a transient gait deficit (hemiparesis) may be seen with prosencephalic infarcts.IV.Vestibular signs may be seen with thalamic infarcts.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition ::: Cerebrovascular Disease ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Serial blood pressure measurements may indicate hypertension.II.Results of a CBC, biochemistry profile, and urinalysis vary, depending on the presence of an underlying systemic disease.III.Additional tests may include urine protein: creatinine ratio, serum antithrombin III activity, coagulation profile, and endocrine testing for hyperadrenocorticism, thyroid diseases, and pheochromocytoma.IV.Thoracic radiography and abdominal ultrasonography may reveal evidence of an underlying disease.V.\nMRI (and occasionally CT) may reveal ischemic brain lesions.VI.CSF analysis usually shows normal to mild increases in nucleated cells, with elevated protein content.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition ::: Cerebrovascular Disease ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.MeningoencephalitisII.Metabolic encephalopathyIII.Neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition ::: Cerebrovascular Disease ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.No definitive treatment for the neurologic signs has been defined in animals.II.Osmotic therapy (as described for cranial trauma) may be beneficial in severely affected animals.III.Treatment is usually directed at the underlying disease.IV.Prognosis and recovery are highly variable.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition ::: Cerebrovascular Disease ::: METABOLIC/TOXIC DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic encephalopathy can arise from thiamine deficiency (de Lahunta, 1983).II.Commercial rations or homemade diets may be low in thiamine.III.Overcooking food before feeding or during food processing can affect thiamine levels.IV.Thiamine can be destroyed by sulfites or sulfur dioxide used as a preservative in canned food.V.All-fish diets may result in thiamine deficiency, as many fish contain thiaminase.VI.Severe hepatic or renal disease can be associated with thiamine deficiency.\n",
            "cite_spans": [
                {
                    "start": 64,
                    "end": 80,
                    "mention": "de Lahunta, 1983",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Definition and Causes ::: Definition and Causes ::: Thiamine Deficiency ::: NUTRITIONAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Thiamine is essential for complete oxidation of glucose through the Krebs cycle.II.Tissues that derive energy from glucose or lactate-pyruvate are compromised.III.Several proposed mechanisms for neuronal cell death include impaired vascular function, increased blood-brain barrier permeability, N-methyl-D-aspartic acid receptor-mediated excitotoxicity, and increased free radical formation (Leong and Butterworth, 1996).IV.CNS lesions include bilateral, symmetrical degeneration of brainstem nuclei (caudal colliculi, vestibular, lateral geniculate, oculomotor and red nuclei), and cortical lesions (less common).\n",
            "cite_spans": [
                {
                    "start": 395,
                    "end": 422,
                    "mention": "Leong and Butterworth, 1996",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Pathophysiology ::: Definition and Causes ::: Thiamine Deficiency ::: NUTRITIONAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs are related to dysfunction of brainstem nuclei and include vestibular ataxia, seizures, dilated pupils, opisthotonus, coma, and death.II.Severe head and neck ventriflexion is often present from neuromuscular weakness.III.Dogs may have signs of central (bilateral) vestibular disease or cervical myelopathy (Garosi et al., 2003).\n",
            "cite_spans": [
                {
                    "start": 316,
                    "end": 335,
                    "mention": "Garosi et al., 2003",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Clinical Signs ::: Definition and Causes ::: Thiamine Deficiency ::: NUTRITIONAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.History, signalment, clinical signs, and response to treatment allow a presumptive diagnosis.II.MRI may disclose symmetrical lesions in affected brainstem nuclei (Garosi et al., 2003).III.Serum levels of pyruvate and lactate may be increased.IV.Red blood cell transketolase activity is usually decreased.\n",
            "cite_spans": [
                {
                    "start": 166,
                    "end": 185,
                    "mention": "Garosi et al., 2003",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Diagnosis ::: Definition and Causes ::: Thiamine Deficiency ::: NUTRITIONAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.MeningoencephalitisII.Metabolic or toxic encephalopathiesIII.NeoplasiaIV.Other causes of central vestibular disease\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Thiamine Deficiency ::: NUTRITIONAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Even in severely affected animals, prognosis is fair to good if signs are recognized early.II.Thiamine HCl (vitamin B1) is administered at 25 to 50 mg/day IM to dogs for 3 to 7 days, and at 10 to 20 mg/day IM to cats until signs abate, or for 21 days.III.Higher doses may be required in some animals.IV.Dietary abnormalities should also be corrected.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Thiamine Deficiency ::: NUTRITIONAL DISORDERS",
            "ref_spans": []
        },
        {
            "text": "\nI.Primary brain tumors arise from neuroectodermal or mesodermal cells that are normally present within or associated with the brain (Summers et al., 1995).II.Secondary tumors originate from surrounding tissues and extend into the brain or arise from hematogenous metastasis.III.Classification of brain tumors (primary or secondary) is based on characteristics of the constituent cell types (Bagley et al., 1993).\n",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 154,
                    "mention": "Summers et al., 1995",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 392,
                    "end": 411,
                    "mention": "Bagley et al., 1993",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Definition ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.Primary tumorsA.Tumors of neuroepithelium1.Astrocytic tumors: astrocytoma, glioblastoma multiforme2.Oligodendroglial tumors: oligodendroglioma3.Mixed glial tumors: oligoastrocytoma, gliomatosis cerebri4.Embryonal tumors: primitive neuroectodermal tumors (PNETs), medulloblastoma5.Ependymoma6.Choroid plexus tumors\nB.Tumors of meninges: meningioma, meningeal sarcomaC.Tumors of hematopoietic tissue: lymphoma, histiocytic tumorsD.Nerve sheath tumorsE.Tumors of the sellar region1.Pituitary tumors: adenoma, adenocarcinoma2.Suprasellar germ cell tumors\n\nII.\nMetastatic tumorsA.HemangiosarcomaB.Urogenital tumors: prostatic carcinoma, mammary gland adenocarcinomaC.Malignant melanoma\nIII.Secondary tumors of adjacent tissuesA.Tumors arising from the calvaria: osteosarcoma, multilobulated tumor of boneB.Local extension of regional tumors1.Nasal tumor: adenocarcinoma, fibrosarcoma2.Tumors arising from the ear or osseous bullae: adenocarcinoma, squamous cell carcinoma\n\n\n",
            "cite_spans": [],
            "section": "Causes and Classification ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.Direct effects of tumor growth include compression and invasion of normal brain parenchyma.II.Indirect effects are often more significant than direct effects.A.Damage to the blood-brain barrier can result in cerebral edema.B.Obstruction to CSF flow causes secondary hydrocephalus.C.Brain herniation can occur as a result of increased intracranial pressure from an enlarging space-occupying mass within the rigid calvaria.D.Hemorrhage is also a possibility.\n\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.Breed predisposition has been reported for several tumors.A.Brachycephalic breeds (especially the boxer, English bulldog, and Boston terrier) are predisposed to gliomas (astrocytomas, oligodendrogliomas, mixed tumors) and pituitary tumors.B.Dolichocephalic dogs and Siamese cats may be predisposed to meningiomas.\nII.Onset of disease may be acute or insidious, depending on the location, rate of growth, and indirect effects of the tumor.III.Neurological signs reflect the location of the tumor.A.Cerebral or thalamic tumors (prosencephalic tumors) may cause seizures, circling, behavioral changes, contralateral postural reaction deficits, contralateral visual deficits, and contralateral nasal hypalgesia.B.Brainstem tumors can induce vestibular signs, ipsilateral postural reaction deficits, cranial nerve deficits, ataxia (both proprioceptive and vestibular), and changes in mentation.C.Cerebellar tumors can result in a wide stance; spastic, hypermetric gait (cerebellar ataxia); loss of balance; intention tremors; ipsilateral postural reaction deficits; and ipsilateral, absent menace response without visual deficits.D.Tumors of the floor of the calvaria may cause deficits of the oculomotor, trochlear, abducens nerves, and the ophthalmic branch of the trigeminal nerve.1.Disruption of the sympathetic innervation to the head may also occur.2.Clinical signs may include ophthalmoplegia, Horner's syndrome, mydriasis, and trigeminal sensory deficits involving the eye and the medial canthus.\n\nIV.Metastatic tumors may involve single or multiple areas within the CNS and be associated with focal or multifocal signs.V.Tumors involving the frontal and olfactory lobes of the cerebrum may cause seizures or changes in mentation without other deficits.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.A minimum database includes a CBC, biochemistry pro-file, urinalysis, and three radiographic views of the thorax.II.MRI and CT may allow a presumptive diagnosis.A.Meningiomas often are extraaxial (on the periphery of the brain), have a broad-based attachment, and exhibit strong, homogeneous contrast enhancement.B.Glial tumors often are intraaxial (within brain parenchyma), display variable contrast enhancement, and occasionally have a ring-enhancement pattern.C.Choroid plexus tumors are located intraventricularly or at the cerebellomedullary angle and typically exhibit strong, uniform contrast enhancement.D.Tumors can occur in the ventricles, such as choroid plexus and ependymal tumors.E.Secondary consequences include compression of normal brain structures with shifting of midline structures, obstructive hydrocephalus, and cerebral (vasogenic) edema.\nIII.CSF analysis often reveals nonspecific abnormalities.A.An increased protein concentration and a normal cell count are typical.B.Neoplastic lymphocytes may be seen with lymphoma.C.Meningiomas may result in a neutrophilic pleocytosis from tumor necrosis.D.An increased risk of brain herniation is associated with elevated intracranial pressure and is a contraindication to CSF tap.\nIV.Definitive diagnosis requires histopathologic evaluation.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.Metabolic or toxic encephalopathiesII.Meningoencephalitis: infectious, noninfectiousIII.Vascular disordersIV.Other causes of seizures, altered mentation\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.Certain treatments are directed at the secondary consequences.A.Osmotic diuretics are used to draw edema out of the brain.1.Give mannitol at 0.25 to 1.0 g/kg IV over 10 to 15 minutes.2.Administer furosemide (0.7 mg/kg IV) 15 minutes after mannitol to prolong the effects of mannitol.3.Administer hypertonic saline at 1.0 to 2.0 mL/kg IV over 10 to 15 minutes.4.\nRepeat osmotic therapy up to every 6 hours unless the animal becomes dehydrated or hypovolemic.5.Evaluate packed cell volume (PCV) and total solids (TS) before administration of osmotic therapy to evaluate hydration status.6.Do not use osmotic therapy in dehydrated, hypovolemic animals, or in animals with decreased cardiac function.\nB.Prednisone (0.5 to 1.0 mg/kg PO, IV) can be administered to reduce peritumoral (vasogenic) edema and inflammation.C.Anticonvulsants are administered for seizures.1.Phenobarbital (2.0 to 4.0 mg/kg PO, IM, IV BID) is usually the first option.2.KBr (30 mg/kg PO SID) may also be added.3.Animals with intracranial neoplasia may become extremely sedate with anticonvulsants.4.Dosages less than the recommended amount may be used initially to avoid extreme sedation.\n\nII.Definitive treatment includes surgery and/or radiation therapy.A.Surgery allows for tumor resection or cytoreduction and provides a histological diagnosis.B.Surgery often is reserved for tumors that are extraaxial (superficial), and more easily approached and removable.C.Radiation therapy (alone or in combination with surgery) has been shown to increase survival time (Axlund et al., 2002; Bley et al., 2005).D.Overall prognosis is fair to guarded and depends on the location and type of tumor.\n\n",
            "cite_spans": [
                {
                    "start": 1538,
                    "end": 1557,
                    "mention": "Axlund et al., 2002",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1559,
                    "end": 1576,
                    "mention": "Bley et al., 2005",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Treatment and Monitoring ::: Definition ::: Definition ::: NEOPLASIA",
            "ref_spans": []
        },
        {
            "text": "\nI.Neurological dysfunction secondary to head trauma is caused by brain contusion, laceration, edema, or hemorrhage.II.Trauma may occur from a fall, automobile accident, or blunt or penetrating injuries.\n",
            "cite_spans": [],
            "section": "Definition and Causes ::: Definition and Causes ::: Definition and Causes ::: CRANIAL TRAUMA",
            "ref_spans": []
        },
        {
            "text": "\nI.Depressed skull fractures may cause compression and injury to underlying brain parenchyma.II.Angular acceleration of the brain can cause diffuse, axonal injury.III.The impact of the brain against the skull results in coup (occurring in tissue under the area of impact) and contrecoup injuries (occurring in tissue on the side opposite the impact).IV.Hemorrhage and hematoma formation can compress brain parenchyma.V.The end result is vasogenic edema of the brain.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Definition and Causes ::: Definition and Causes ::: CRANIAL TRAUMA",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs may be indicative of focal or diffuse brain disease.II.Prosencephalic injury may result in loss of consciousness in severe cases, but more frequently leads to circling, altered mentation, and contralateral postural reaction deficits, blindness, and facial hypalgesia.III.Brainstem injury typically causes altered mentation (depression, obtundation, or sometimes a comatose state), pupillary changes, and loss of conjugate eye movementsIV.Cerebellovestibular injury can result in dysmetria, cerebellar or vestibular ataxia, dysequilibrium, head tilt, and spontaneous or positional nystagmus.V.Evidence of progressive clinical signs suggests cerebral edema, herniation, or hematoma formation.\n",
            "cite_spans": [],
            "section": "Clinical Signs ::: Definition and Causes ::: Definition and Causes ::: CRANIAL TRAUMA",
            "ref_spans": []
        },
        {
            "text": "\nI.Signs of brain dysfunction in an animal known to have suffered an injury are suggestive.II.Abrasions, penetrating wounds, or other evidence of head trauma are supportive.III.Although difficult to interpret, radiographs may reveal skull fractures.IV.MRI or CT can identify skull fractures, areas of hemorrhage, hematoma formation, and edema within the brain.\n",
            "cite_spans": [],
            "section": "Diagnosis ::: Definition and Causes ::: Definition and Causes ::: CRANIAL TRAUMA",
            "ref_spans": []
        },
        {
            "text": "\nI.Other disorders are considered if trauma was not wit-nessed or if external evidence of trauma is absent.II.Consider metabolic and toxic encephalopathies, as well as inflammatory, vascular, and neoplastic disorders.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Definition and Causes ::: Definition and Causes ::: CRANIAL TRAUMA",
            "ref_spans": []
        },
        {
            "text": "\nI.Nonspecific therapy is often initiated before or in conjunction with specific therapies.A.Ensure airway patency, adequate ventilation, and stabilize cardiovascular function.B.Institute fluid therapy to correct any hypovolemia and associated hypotension.C.Provide oxygen to prevent further tissue hypoxia.D.Turn recumbent animals every 6 hours, and keep them clean and well padded.E.Provide nutritional support after they are stabilized.\nII.Specific therapy is directed at reducing cerebral edema and intracranial pressure.A.Recumbent animals are positioned with their heads slightly elevated (15 to 30 degrees).B.Osmotic therapy is started for cerebral edema.1.Mannitol 0.25 to 1.0 g/kg IV over 10 to 15 minutes2.Hypertonic saline 7% 1 to 5 mL/kg IV over 3 to 5 minutes3.Furosemide (0.7 mg/kg IV) can be given 15 minutes after mannitol to prolong its effect.4.Osmotic therapy can be repeated every 6 to 8 hours unless dehydration or hypernatremia develops.5.Electrolytes, PCV, and TS are monitored closely with osmotic therapy.\nC.Osmotic therapy is contraindicated in hypovolemic animals and those with clinical signs suggestive of active intracranial hemorrhage.D.Surgery is indicated for depressed skull fractures or if the animal's condition deteriorates despite medical management.\nIII.\nPrognosis depends on the severity and location of the injury.IV.Although most improvements are seen within the first month of the injury, recovery may take weeks to months.V.Long-term sequelae may include seizures and persistent neurological deficits.\n",
            "cite_spans": [],
            "section": "Treatment and Monitoring ::: Definition and Causes ::: Definition and Causes ::: CRANIAL TRAUMA",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "TABLE 23-1: Breed-Associated Degenerative Disorders of the Brain\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "TABLE 23-2: Disorders of Intermediary Metabolism (Storage Diseases)\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "TABLE 23-3: Causes of Metabolic or Toxic Encephalopathies\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs",
            "authors": [
                {
                    "first": "FP",
                    "middle": [],
                    "last": "Adamo",
                    "suffix": ""
                },
                {
                    "first": "RT",
                    "middle": [],
                    "last": "O'Brien",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Am Vet Med Assoc",
            "volume": "225",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Long-term treatment of dogs with steroid responsive meningitis-arteritis: clinical, laboratory and therapeutic results",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cizinauskas",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jaggy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tipold",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Small Anim Pract",
            "volume": "41",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "de Lahunta",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Veterinary Neuroanatomy and Clinical Neurology",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Foramen magnum decompression for treatment of caudal occipital malformation syndrome in dogs",
            "authors": [
                {
                    "first": "CW",
                    "middle": [],
                    "last": "Dewey",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Berg",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Barone",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Am Vet Med Assoc",
            "volume": "227",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Diagnostic features of clinical neurologic feline infectious peritonitis",
            "authors": [
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Foley",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Lapointe",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Koblik",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Vet Intern Med",
            "volume": "12",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Thiamine deficiency in a dog: clinical, clinicopathologic, and magnetic resonance imaging findings",
            "authors": [
                {
                    "first": "LS",
                    "middle": [],
                    "last": "Garosi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dennis",
                    "suffix": ""
                },
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Platt",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Vet Intern Med",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Results of diagnostic investigations and long-term outcome of 33 dogs with brain infarction (2000-2004)",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Garosi",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "McConnell",
                    "suffix": ""
                },
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Platt",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Vet Intern Med",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Clinical and clinicopathologic features in 11 cats with Cuterebra larvae myiasis of the central nervous system",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Glass",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cornetta",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "deLahunta",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Vet Intern Med",
            "volume": "12",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "",
            "authors": [
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Greene",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Infectious Diseases of the Dog and Cat",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Facial neuropathy in dogs and cats: 95 cases (1975-1985)",
            "authors": [
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Kern",
                    "suffix": ""
                },
                {
                    "first": "HN",
                    "middle": [],
                    "last": "Erb",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "J Am Vet Med Assoc",
            "volume": "191",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Immunohistochemical charac-terization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kipar",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Baumgartner",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vogl",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Vet Pathol",
            "volume": "35",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Glutamine as a pathogenic factor in hepatic encephalopathy",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Albrecht",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dolinska",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Neurosci Res",
            "volume": "65",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Fungal infections of the central nervous system in the dog and cat",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lavely",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lipsitz",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Tech Small Anim Pract",
            "volume": "20",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging",
            "authors": [
                {
                    "first": "DK",
                    "middle": [],
                    "last": "Leong",
                    "suffix": ""
                },
                {
                    "first": "RF",
                    "middle": [],
                    "last": "Butterworth",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Metab Brain Dis",
            "volume": "11",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Platt",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Olby",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "BSAVA Manual of Canine and Feline Neurology",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Bacterial meningoencephalomyelitis in dogs: a retrospective study of 23 cases (1990-1999)",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Radaelli",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Platt",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Vet Intern Med",
            "volume": "16",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Syringohydromyelia in Cavalier King Charles spaniels",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rusbridge",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "MacSweeny",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Davies",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Am Anim Hosp Assoc",
            "volume": "36",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Polymerase chain reaction (PCR) amplification of parvoviral DNA from the brains of dogs and cats with cerebellar hypoplasia",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Schatzberg",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Haley",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Barr",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Vet Intern Med",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Eosinophilic meningoencephalitis in a cat",
            "authors": [
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Schultze",
                    "suffix": ""
                },
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Cribb",
                    "suffix": ""
                },
                {
                    "first": "HW",
                    "middle": [],
                    "last": "Tvedten",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "J Am Anim Hosp Assoc",
            "volume": "22",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Recognition and diagnosis of lysosomal storage diseases in the cat and dog",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Skelly",
                    "suffix": ""
                },
                {
                    "first": "RJ",
                    "middle": [],
                    "last": "Franklin",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Vet Intern Med",
            "volume": "16",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Cerebrospinal fluid analysis and clinical outcome of eight dogs with eosinophilic meningoencephalomyelitis",
            "authors": [
                {
                    "first": "LL",
                    "middle": [],
                    "last": "Smith-Maxie",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Parent",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rand",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "J Vet Intern Med",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Necrotizing meningoencephalitis of Maltese dogs",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Stalis",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Chadwick",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Dayrell-Hart",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Vet Pathol",
            "volume": "32",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Surgery alone or in combination with radiation therapy for treatment of intracranial meningiomas in dogs: 31 cases (1989-2002)",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Axlund",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "McGlasson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Am Vet Med Assoc",
            "volume": "221",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Summers",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cummings",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "de Lahunta",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Veterinary Neuropathology",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Necrotizing encephalitis in Yorkshire terriers",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tipold",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fatzer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jaggy",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "J Small Anim Pract",
            "volume": "34",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Steroid-responsive meningitis-arteritis in dogs with noninfectious, nonerosive, idiopathic, immune-mediated polyarthritis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Webb",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Muir",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Vet Intern Med",
            "volume": "16",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Cerebrospinal cuterebrosis in cats and its association with feline ischemic encephalopathy",
            "authors": [
                {
                    "first": "KJ",
                    "middle": [],
                    "last": "Williams",
                    "suffix": ""
                },
                {
                    "first": "BA",
                    "middle": [],
                    "last": "Summers",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "de Lahunta",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Vet Pathol",
            "volume": "35",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown etiology in ten dogs",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zarfoss",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Schatzberg",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Venator",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Small Anim Pract",
            "volume": "47",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bagley",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kornegay",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Page",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Textbook of Small Animal Surgery",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "An unusual neurological disorder in the Labrador retriever",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Barone",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "de Lahunta",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sandler",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Vet Intern Med",
            "volume": "14",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Irradiation of brain tumors in dogs with neurologic disease",
            "authors": [
                {
                    "first": "CR",
                    "middle": [],
                    "last": "Bley",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sumova",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Roos",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Vet Intern Med",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Braund",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Braund's Clinical Neurology in Small Animals: Localization, Diagnosis and Treatment",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Review of idiopathic feline vestibular syndrome in 75 cats",
            "authors": [
                {
                    "first": "EE",
                    "middle": [],
                    "last": "Burke",
                    "suffix": ""
                },
                {
                    "first": "NS",
                    "middle": [],
                    "last": "Moise",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "deLahunta",
                    "suffix": ""
                }
            ],
            "year": 1985,
            "venue": "J Am Vet Med Assoc",
            "volume": "187",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "A necrotizing meningoencephalitis of pug dogs",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cordy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Holliday",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Vet Pathol",
            "volume": "26",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}